Fertility supplement Market Size, Share, Competitive Landscape and Trend Analysis Report, by Ingredient, Product and End User : Global Opportunity Analysis and Industry Forecast, 2020-2030

Fertility supplement market Overview 

The fertility supplements market size generated $1,754.00 million in 2020 and is projected to reach $3,652.50 million by 2030, growing at a CAGR of 7.50% from 2021 to 2030.Fertility supplements have been shown to prompt ovulation, improve hormonal profiles, and increase pregnancy and delivery rates for women and men. Infertility can occur in men or women of child-bearing age. In addition, male infertility is identified majorly as a result of low sperm count or decreased motility of sperms, which may be due to hormonal imbalance. Hence, fertility in men and women requires proper functioning of hypothalamus and pituitary gland. Increase in the rate of infertility has occurred majorly due to factors such as increase in the consumption of alcohol and drugs, increased stress level, frequent smoking, obesity, and environmental factors. As per a study by the American Society for Reproductive medicines, in approximately 40% of infertile couples, the male partner is responsible for infertility and among them, approximately 85%–90% are treated with drugs or surgery. Hence, positively impacting the market growth.

Various government activities are organized to increase awareness regarding the fertility supplements and further advancements in research and development that have helped the decision markers to choose supplements considering their past illness. At present, many people are focused on improving sexual wellbeing and eager to spend more on fertility supplements, this would drive the growth of the fertility supplement market. 

Rise in the fertility rates owing to the increasing consumption of alcoholic beverages, caffeine and smoking is a major factor driving the growth. It is expected to be driven by the declining fertility rates in the quantity of smokers with the rise in the utilization of liquor and caffeine. Rising geriatric population, human services costs, evolving way of life, clinical revelations and assumptions about the significant expenses of fertility supplements have supported the general market development as well as product demand. The fertility medications may not be useful for females undergoing UVR treatment considering the consumption caffeine and smoking is the major factor that impacts the effect of supplements on the body. Further, expanding significance of food items for example avocados, olive oil, entire grains and high fat dairy items utilized in expanding fertility is required to enhance the extent of functional food and drinks in future. The important factors are rising geriatric population and the increasing inclination toward preventive measure for fertility, which includes fertility supplements. Moreover, rise in infertility rates are not only due to lifestyle changes but also due to various diseases such as sexually transmitted diseases (STDs) and fertility-related diseases. Hence, the increase in infertility rates in the near future is anticipated to augment the growth of the fertility supplements market.

Fertility Supplement Market Segmentation

The global fertility supplement market is classified into ingredient, product, end user, and region. By ingredient, the market is divided into natural, and synthetic/blend of natural & synthetic. By product, it is categorized into capsules, tablets, soft gels, powders, and liquids. By end user, the market is segmented into men and women. On the basis of region, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, the UK, France, Spain, Italy, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa and rest of LAMEA).

Segment review

By ingredient, the natural segment accounted for more than half of the market share in fertility supplement market in 2020. This segment is expected to exhibit a prominent growth rate, owing to, introduction of innovative products and technological advancements in health and wellness industry are anticipated to boost the growth of natural fertility supplement segment over the forecast period. Increasing utilization of plant-derived products for a healthy lifestyle and to reduce the risk of side effects is expected to further propel the demand in the near future. Moreover, by product, the capsules segment accounted for major share of the market share in fertility supplement market in 2020. These products enable unique mixes of ingredients, provide protection from sensitive ingredients, reduce gastrointestinal irritation, and ensure oil and fat-soluble nutrient delivery. This factor is anticipated to boost the segment growth.

By end user, the women segment accounted for major share of the market share in fertility supplement market in 2020. This segment is expected to exhibit a considerable growth rate. Immune system factors, hypogonadism, varicocele, systemic disease, sexual factors, urogenital infection are some of the prominent factors leading to fertility problems in women.

Asia-Pacific presents lucrative opportunities for key players operating in the fertility supplement market, owing to increase in accessibility and availability of healthcare facilities and rise in healthcare and research expenditure. This region is anticipated to experience rapid market growth due to economic development. Moreover, rising awareness in China and India regarding nutritional enrichment is expected to remain a favorable factor for regional growth. Furthermore, expansion in retail market in emerging markets including China, Indonesia, Malaysia, and India in light of regulatory support to promote investments is expected to increase the accessibility to buyers over the forecast period.

The key players operating in the global fertility supplement market include Fairhaven Health, Coast Science, Lenus Pharma GesmbH, Active Bio Life Science GmbH, Orthomol, Exeltis USA, Inc.,PregPrep LLC, Bionova, TTK HealthCare Ltd.,Fertility Nutraceuticals LLC.

Key Benefits For Stakeholders

• The study provides an in-depth analysis of the fertility supplement market, and the current trends and future estimations to elucidate the imminent investment pockets.
• It presents a quantitative analysis of the market from 2020 to 2030 to enable stakeholders to capitalize on the prevailing fertility supplements market opportunities.
• Extensive analysis of the market based on procedures and services assists to understand the trends in the industry.
• Key players and their strategies are thoroughly analyzed to understand the competitive outlook of the fertility supplements market.

Key Market Segments

By Ingredient

• Natural
• Synthetic/Blend of Natural & Synthetic 

By Product

• Capsules
• Tablets
• Soft Gels
• Powders
• Liquids

By End User

• Men
• Women

By Region

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
• Asia-Pacific
  • Japan
  • China
  • India
  • Australia
  • Rest of Asia-Pacific
• LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA

  Fertility supplement Market Report Highlights

Aspects	Details
By INGREDIENTS	Natural Synthetic and blend
By PRODUCT	Capsules Tablets Soft Gels Powders Liquids
By END USER	Men Women
By Region	North America  (U.S., Canada, Mexico) Europe  (France, Germany, Italy, Spain, UK, Russia, Rest of Europe) Asia-Pacific  (China, Japan, India, South Korea, Australia, Thailand, Malaysia, Indonesia, Rest of Asia-Pacific) LAMEA  (Brazil, South Africa, Saudi Arabia, UAE, Argentina, Rest of LAMEA)
Key Market Players	Bionova, Orthomol, PregPrep LLC, Fertility Nutraceuticals LLC., Fairhaven Health, Exeltis USA, Inc., Lenus Pharma GesmbH,, Coast Science, TTK HealthCare Ltd., Active Bio Life Science GmbH

Analyst Review

This section provides the opinions of the top-level CXOs in the fertility services industry. According to the CXOs, the fertility supplements market is anticipated to witness considerable growth in future, owing to rise in prevalence of infertility, emerging trend of delayed pregnancies among women, surge in male infertility.

Moreover, increase in awareness about fertility supplements and surge in popularity of medical & fertility tourism coupled with advanced treatment options are anticipated to supplement the market growth. However, high prices of fertility supplements may discourage their purchase to an extent, especially in underdeveloped economies are expected to impede the market growth during the forecast period.

Rising consumption of plant extracts, particularly herbs, in pharmaceutical industry owing to increasing awareness regarding biologically-derived ingredients is expected to reduce the availability of raw materials among natural food product manufacturers over the next seven years. Furthermore, several governments have been funding studies to boost the adoption of natural products, which is expected to propel the product demand during the forecast period.

Author Name(s) : Apoorva Srivastava | Roshan Deshmukh

Related Tags

• Ivf
• Fertility
• Gynecology